Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-02-17
2010-10-26
Fetterolf, Brandon J (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C564S123000, C564S308000, C564S427000, C568S306000, C514S629000
Reexamination Certificate
active
07820681
ABSTRACT:
Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided.
REFERENCES:
patent: 5426224 (1995-06-01), Lee et al.
patent: 5914332 (1999-06-01), Sham et al.
patent: 6037157 (2000-03-01), Norbeck et al.
patent: 6896900 (2005-05-01), Gosselin et al.
patent: 7601758 (2009-10-01), Davis
patent: 7619004 (2009-11-01), Davis
Leikin et al. Poisoning and toxicology handbook. Aug. 2007, p. 216.
Herrewege et al. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides. Antiviral Research, 74, 2007, 111-124.
Creighton et al. Is ritonavir boosting associated with gout? International journal of STD & AIDS, 2005, 16: 362-364.
Vision Pharma (Colchicine Tablets USP, 0.6 mg, 2006).
Leikin et al. Poisoning and toxicology handbook. Aug. 2007, pp. 216-217.
Temesgen et al. Tipranavir: a new option for the treatment of drug-resistant HIV infection. Reviews of Anti-infective agents. Sep. 15, 2007.
Wang et al. 2001. HMG-CoA reductase inhibitors (statins) characterized as direct inhibition of P-glycoprotein. Pharmaceutical esearch, vol. 18, No. 6, pp. 800-806.
Drugs.Com; “Colchicine and Ritonavir Interactions”; printed Jan. 5, 2009; “colchicine”, printed Jan. 9, 2009: and “ritonavir”, printed Jan. 9, 2009.
Horn, et al.; “Life-Threatening Colchicine Drug Interactions”; Pharmacy Times; p. 111; (May 2006).
Hsu, et al.,; “Ritonavir: Clinical Pharmacokinetics and Interactions with Other Anti-HIV Agents”; Clinical Pharmacokinet; 35; pp. 275-291; (1998).
Niel, et al.; “Colchicine Today”; Joint Bone Spine; 73; pp. 672-678; (2006).
Perez-Ruiz, et al.; “Optimisation of the Treatment of Acute Gout”; BioDrugs; 13; pp. 415-423; (2000).
Terkeltaub, Robert A.; “Gout”; The New England Journal of Medicine; 349; pp. 1647-1655; (2003).
Van Der Velden, et al.; “Colchicine-Induced Neuromyopathy in a Patient with Chronic Renal Failure: The Role of Clarithromycin”; Netherlands Journal of Medicine; 66; pp. 204-206; (2008).
Zhou, et al.; “Clinical Outcomes and Management of Mechanism-Based Inhibition of Cytochrome P450 3A4” ; Therapeutics and Clinical Risk Management; I; pp. 3-13; (2005).
Terkeltaub, et al.; “Comparison of Low-Dose vs High-Dose Oral Colchicine Regimens in Patients with Gout Flares”; Presentation at the American College of Rheumatology Scientific Meeting in San Francisco, CA; 23 pages; Oct. 24-29 (2008).
Terkeltaub, et al.; “The Clinical Relevance of P-gp and CYP 3A4 on Colchicine Metabolism and Elimination: Dosing Recommendations for Macrolide Antibiotics, Cyclosporine, Ketoconazole, Ritonavir and Diltiazem”; Presentation at the American College of Rheumatology Scientific Meeting in San Francisco, CA; 19 pages; Oct. 24-29 (2008).
Krishnan et al.; “Gout in Ambulatory Care Settings in the United States”; Journal of Rheumatology; 35; pp. 498-501; (2008).
Lacy et al. Lexi-Comp's Clinical Reference Library, Drug Information Handbook, 7th Edition, 1999-2000), pp. 108-109 and 292-293.
Cantor & Colburn LLP
Fetterolf Brandon J
Mutual Pharmaceutical Company, Inc.
Pagonakis Anna
LandOfFree
Methods for concomitant administration of colchicine and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for concomitant administration of colchicine and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for concomitant administration of colchicine and a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4219151